权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Circuit Mechanisms of Psilocybin Following Chronic Stress

慢性应激后裸盖菇素的回路机制

基本信息

批准号：
10642817
负责人：
Omar Jamil Ahmed
金额：
$ 39万
依托单位：
UNIVERSITY OF MICHIGAN AT ANN ARBOR
依托单位国家：
美国
项目类别：
财政年份：
2022
资助国家：
美国
起止时间：
2022-06-10 至 2027-04-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10642817
关键词：
Address Atrophic Brain Brain region Chronic Chronic stress Claustral structure Coupling Dendritic Spines Dose Electrodes Electrophysiology (science)Excitatory Synapse Exhibits Genes Glutamates Growth Hallucinogens Human Impairment Investigation Ketamine Knock-out Knowledge Maps Modification Morphology Mus Neuronal Plasticity Neurons Patients Pharmacological Treatment Physiological Physiology Play Population Prefrontal Cortex Property Psilocybin Pyramidal Cells Rodent Role Serotonin Serotonin Receptor 5-HT2A Sleep Specificity Stress Structure Synapses Thalamic structure Therapeutic Therapeutic Effect Vertebral column antagonist awake cell type cognitive reappraisal density design efficacious treatment emotion regulation functional disability hippocampal pyramidal neuron in vivo neural circuit neuropsychiatric disorder neuropsychiatry neurotransmission optogenetics postsynaptic presynaptic receptor expression repaired stress related disorder transcriptomics transmission process treatment response

项目摘要

ABSTRACT / PROJECT SUMMARY Chronic stress is thought to play a role in multiple neuropsychiatric disorders. Standard pharmacological treatments for stress-related disorders can take up to several months to elicit a therapeutic response and can produce long-term undesirable off-target effects. A single dose of the psychedelic drug psilocybin has been shown to rapidly promote long-lasting therapeutic effects in humans and in chronically stressed rodents. However, the neural circuit mechanisms underlying the lasting changes induced by psilocybin in healthy and chronically stressed brains remain unknown. The prefrontal cortex (PFC) is a key structure impacted by chronic stress. Decreased volume, hypoactivity, and impaired functional connectivity of the PFC has been observed in humans with stress-related disorders. Similarly, PFC pyramidal cells in chronically stressed rodents exhibit dendritic atrophy and excitatory synapse loss. Psilocybin enhances expression of neuroplasticity-related genes through a cascade involving the activation of the serotonin 5-HT2A receptor (5-HT2AR). While the 5-HT2AR is expressed postsynaptically in many cell-types, including PFC pyramidal cells, presynaptic 5-HT2ARs are also known to regulate synaptic input to PFC pyramidal neurons. Psilocybin induces dendritic growth and increases dendritic spine density in PFC pyramidal cells after a single dose. However, no studies to date have examined the rules governing which synapses (and which corresponding dendritic spines) are restored: does psilocybin non-specifically increase spine and synapse number, or does it preferentially enhance spines and synapses corresponding to specific inputs with higher 5-HT2AR expression? Answering this question is a critical step towards a mechanistic understanding of how psilocybin exerts therapeutic effects. To address this gap in knowledge, we will conduct a multiscale investigation of the effects of psilocybin on multiple brain regions. Our central hypothesis is that the synaptic inputs to PFC that are impaired following chronic stress are restored in an input-specific manner by psilocybin. In Aim 1, we will characterize the effects of psilocybin in vivo on input-specific changes in PFC connectivity and dynamics in chronically stressed rodents. In Aim 2, we will use both in vivo and ex vivo optogenetics to determine the effects of chronic stress and subsequent psilocybin treatment on input-specific synaptic physiology and dendritic morphology. The completion of these Aims will identify input-specific rules governing psilocybin-induced normalization of impaired prefrontal circuits, with important implications for the design of even more precise and efficacious neuropsychiatric therapies with minimal off-target effects.

摘要/项目总结